USA - NASDAQ:MGRX - US56270V2051 - Common Stock
The current stock price of MGRX is 2.27 USD. In the past month the price increased by 43.67%. In the past year, price decreased by -43.95%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
GRDN | GUARDIAN PHRMCY SERVICES-A | N/A | 1.88B | ||
YI | 111 INC | N/A | 50.71M | ||
RDGT | RIDGETECH INC | 0.77 | 7.91M | ||
SRXH | SRX HEALTH SOLUTIONS INC | N/A | 4.72M |
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. The company has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
MANGOCEUTICALS INC
15110 Dallas Pkwy, Suite 600
Dallas TEXAS US
Employees: 3
Phone: 18336264679
The current stock price of MGRX is 2.27 USD. The price increased by 6.57% in the last trading session.
The exchange symbol of MANGOCEUTICALS INC is MGRX and it is listed on the Nasdaq exchange.
MGRX stock is listed on the Nasdaq exchange.
MANGOCEUTICALS INC (MGRX) has a market capitalization of 23.93M USD. This makes MGRX a Nano Cap stock.
MANGOCEUTICALS INC (MGRX) currently has 3 employees.
MANGOCEUTICALS INC (MGRX) has a support level at 2.12 and a resistance level at 2.34. Check the full technical report for a detailed analysis of MGRX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MGRX does not pay a dividend.
MANGOCEUTICALS INC (MGRX) will report earnings on 2025-11-14.
MANGOCEUTICALS INC (MGRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.33).
The outstanding short interest for MANGOCEUTICALS INC (MGRX) is 1.74% of its float. Check the ownership tab for more information on the MGRX short interest.
ChartMill assigns a technical rating of 5 / 10 to MGRX. When comparing the yearly performance of all stocks, MGRX is a bad performer in the overall market: 87.9% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to MGRX. MGRX has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months MGRX reported a non-GAAP Earnings per Share(EPS) of -3.33. The EPS increased by 33.35% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -68.14% | ||
ROE | -73.81% | ||
Debt/Equity | 0.03 |